wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39013616-D18F3462-1D4D-4A85-A31A-56F1A2F4E9BC
Q39013616-D18F3462-1D4D-4A85-A31A-56F1A2F4E9BC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39013616-D18F3462-1D4D-4A85-A31A-56F1A2F4E9BC
Resistance to anticancer immunity in cancer patients: potential strategies to reverse resistance.
P2860
Q39013616-D18F3462-1D4D-4A85-A31A-56F1A2F4E9BC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39013616-D18F3462-1D4D-4A85-A31A-56F1A2F4E9BC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
673b628104e2a8128149cb97db86bb151a5ba837
P2860
Phase 1 study of the safety, pharmacokinetics, and antitumour activity of the BCL2 inhibitor navitoclax in combination with rituximab in patients with relapsed or refractory CD20+ lymphoid malignancies